Cross Country Healthcare buy melinda
Start price
05.09.12
/
50%
€3.54
Target price
05.03.13
€4.00
Performance (%)
23.42%
End price
05.03.13
€4.36
Summary
This prediction ended on 05.03.13 with a price of €4.36. The prediction had a final performance of 23.42%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cross Country Healthcare | -1.460% | -1.460% | -60.294% | -73.425% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
Comments by melinda for this prediction
In the thread Cross Country Healthcare diskutieren
klinischen Studien
Langlauf und Gesundheitsdienstleister von klinischen Studien andere Dienste Human Capital Management konzentriert sich auf Gesundheits-
(Laufzeit überschritten)
Stopped prediction by melinda for Cross Country Healthcare
Cross Country Healthcare
Start price
Target price
Perf. (%)
€7.30
21.12.13
21.12.13
€5.50
23.06.14
23.06.14
-34.93%
23.06.14
23.06.14
